Diffusion weighted MRI: overview and implications for rectal cancer management
Corresponding Author
D. Boone
Department of Imaging, Colchester Hospital University Foundation Trust, Colchester, UK
Correspondence to: Dr Darren Boone MRCS FRCR, Department of Imaging, Colchester Hospital University Foundation Trust, Turner Road, Colchester, CO4 5JL, UK.
E-mail: [email protected]
Search for more papers by this authorS. A. Taylor
Centre for Medical Imaging, University College London, NIHR University College London Hospitals Biomedical Res'earch Centre, London, UK
Search for more papers by this authorS. Halligan
Centre for Medical Imaging, University College London, NIHR University College London Hospitals Biomedical Res'earch Centre, London, UK
Search for more papers by this authorCorresponding Author
D. Boone
Department of Imaging, Colchester Hospital University Foundation Trust, Colchester, UK
Correspondence to: Dr Darren Boone MRCS FRCR, Department of Imaging, Colchester Hospital University Foundation Trust, Turner Road, Colchester, CO4 5JL, UK.
E-mail: [email protected]
Search for more papers by this authorS. A. Taylor
Centre for Medical Imaging, University College London, NIHR University College London Hospitals Biomedical Res'earch Centre, London, UK
Search for more papers by this authorS. Halligan
Centre for Medical Imaging, University College London, NIHR University College London Hospitals Biomedical Res'earch Centre, London, UK
Search for more papers by this authorAbstract
Diffusion weighted imaging (DWI) is an MRI technique that quantifies the movement of water molecules at a cellular level. As the diffusion properties of water vary in areas of necrosis, high cellularity, inflammation and fibrosis, this technique is inherently sensitive to different pathologies. Having become a well-established adjunct to standard sequences during neurological MRI, technological advances have enabled extrapolation to abdominopelvic imaging, including staging of rectal cancer. Scan acquisitions can be performed rapidly using widely available equipment and consequently there has been rapid dissemination into routine practice. However, while DWI shows promise for detecting, staging and monitoring rectal cancer response to therapy, the evidence base remains scant with no current consensus for technical protocols, interpretation or integration into rectal cancer management. Moreover, those studies available to date have a small sample size and few observers, and their results may not be generalizable to daily practice. This article outlines the physical principles of DWI, reviews the literature and suggests avenues for future research into this important technical development.
References
- 1 MERCURY-Study-Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY Study1. Radiology 2007; 243: 132–9.
- 2Beets-Tan RG, Beets GL, Vliegen RF et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497–504.
- 3Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008; 95: 229–36.
- 4Szafer A, Zhong J, Gore JC. Theoretical model for water diffusion in tissues. Magn Reson Med 1995; 33: 697–712.
- 5Koh D-M, Padhani AR. Diffusion-weighted MRI: a new functional clinical technique for tumour imaging. Br J Radiol 2006; 79: 633–5.
- 6Bauerle T, Seyler L, Munter M et al. Diffusion-weighted imaging in rectal carcinoma patients without and after chemoradiotherapy: a comparative study with histology. Eur J Radiol 2012; 82: 444–52.
- 7Soyer P, Lagadec M, Sirol M et al. Free-breathing diffusion-weighted single-shot echo-planar MR imaging using parallel imaging (GRAPPA 2) and high b value for the detection of primary rectal adenocarcinoma. Cancer Imaging 2010; 10: 32–9.
- 8Hosonuma T, Tozaki M, Ichiba N et al. Clinical usefulness of diffusion-weighted imaging using low and high b-values to detect rectal cancer. Magn Reson Med Sci 2006; 5: 173–7.
- 9Cong GN, Qin MW, You H et al. [Diffusion weighted imaging combined with magnetic resonance conventional sequences for the diagnosis of rectal cancer]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2009; 31: 200–5.
- 10Rao SX, Zeng MS, Chen CZ et al. The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection. Eur J Radiol 2008; 65: 299–303.
- 11Mir N, Sohaib S, Colins D, Koh D. Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis. J Med Imaging Radiat Oncol 2010; 54: 358–64.
- 12Nasu K, Kuroki Y, Minami M. Diffusion-weighted imaging findings of mucinous carcinoma arising in the ano-rectal region: comparison of apparent diffusion coefficient with that of tubular adenocarcinoma. Jpn J Radiol 2012; 30: 120–7.
- 13Curvo-Semedo L, Lambregts DM, Maas M, Beets GL, Caseiro-Alves F, Beets-Tan RG. Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging 2012; 35: 1365–71.
- 14Mizukami Y, Ueda S, Mizumoto A et al. Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer. World J Surg 2011; 35: 895–9.
- 15Zhuang XZ, Yu SP, Cui J et al. [Diagnosis value of 3.0 T diffusion-weighted imaging with background suppression magnetic resonance for metastatic lymph nodes in rectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 2011; 14: 842–5.
- 16Yasui O, Sato M, Kamada A. Diffusion-weighted imaging in the detection of lymph node metastasis in colorectal cancer. Tohoku J Exp Med 2009; 218: 177–83.
- 17Lambregts DM, Maas M, Riedl RG et al. Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer-a per lesion validation study. Eur Radiol 2011; 21: 265–73.
- 18Eisenhauer EA, Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228–47.
- 19Dzik-Jurasz A, Domenig C, George M et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002; 360: 307–8.
- 20Hein PA, Kremser C, Judmaier W et al. [Diffusion-weighted MRI–a new parameter for advanced rectal carcinoma?] Rofo 2003; 175: 381–6.
- 21Intven M, Reerink O, Philippens ME. Diffusion-weighted MRI in locally advanced rectal cancer : pathological response prediction after neo-adjuvant radiochemotherapy. Strahlenther Onkol 2012; 19: 19.
- 22Jung SH, Heo SH, Kim JW et al. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging. J Magn Reson Imaging 2012; 35: 110–6.
- 23Barbaro B, Vitale R, Valentini V et al. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy. Int J Radiat Oncol Biol Phys 2012; 83: 594–9.
- 24Kremser C, Judmaier W, Hein P, Griebel J, Lukas P, de Vries A. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 2003; 179: 641–9.
- 25Sun YS, Zhang XP, Tang L et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010; 254: 170–8.
- 26Engin G, Sharifov R, Gural Z et al. Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer? Diagn Interv Radiol 2012; 18: 574–81.
- 27Lim S-B, Yu CS, Hong YS, Kim TW, Kim JH, Kim JC. Long-term outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection. J Surg Oncol 2012; 106: 659–66.
- 28Smith JD, Ruby JA, Goodman KA et al. Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg 2012; 256: 965–72.
- 29Lambregts DM, Vandecaveye V, Barbaro B et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 2011; 18: 2224–31.
- 30Kim SH, Lee JM, Hong SH et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 2009; 253: 116–25.
- 31Gu J, Khong PL, Wang S, Chan Q, Law W, Zhang J. Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT. Mol Imaging Biol 2011; 13: 1020–8.
- 32Ono K, Ochiai R, Yoshida T et al. Comparison of diffusion-weighted MRI and 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for detecting primary colorectal cancer and regional lymph node metastases. J Magn Reson Imaging 2009; 29: 336–40.
- 33Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007 Jun; 188: 1622–35.
- 34Padhani AR, Liu G, Koh DM et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11: 102–25.
- 35Jang KM, Kim SH, Choi D, Lee SJ, Park MJ, Min K. Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results. Br J Radiol 2012; 85: 14.
- 36Lambregts DM, Beets GL, Maas M et al. Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol 2011; 21: 2567–74.